Carteolol is a non-selective beta-adrenergic antagonist primarily indicated for the management of ocular hypertension and glaucoma by reducing intraocular pressure. As part of rigorous pharmaceutical quality… Read more

















Carteolol is a non-selective beta-adrenergic antagonist primarily indicated for the management of ocular hypertension and glaucoma by reducing intraocular pressure. As part of rigorous pharmaceutical quality control and regulatory compliance, analytical laboratories require high-quality reference materials to ensure the safety and efficacy of the drug product. This category includes a comprehensive selection of Carteolol reference standards, along with its related pharmacopeial and non-pharmacopeial impurities. These impurities, often utilized in impurity profiling and method validation, allow chemists to accurately identify and quantify degradation products or process-related substances. Additionally, the collection features stable isotope labelled compounds, such as deuterium-labelled variants, which serve as essential internal standards for mass spectrometry-based bioanalytical assays. These materials are critical for supporting accurate analytical testing and ensuring consistent product quality throughout the drug development lifecycle.